東華大學圖書館 |

語系: 繁體中文

說明(常見問題)

回圖書館首頁

手機版館藏查詢

登入

回首頁

切換: 標籤 | MARC模式 | ISBD

Chemical investigation of candidate ...

Dao, Christine Anh.

FindBook

Google Book

Amazon

博客來

Chemical investigation of candidate probiotics in aquaculture and formulation of a probiotic agent for oyster larviculure.

紀錄類型:	書目-電子資源 : Monograph/item
正題名/作者:	Chemical investigation of candidate probiotics in aquaculture and formulation of a probiotic agent for oyster larviculure./
作者:	Dao, Christine Anh.
面頁冊數:	191 p.
附註:	Source: Dissertation Abstracts International, Volume: 76-07(E), Section: B.
Contained By:	Dissertation Abstracts International76-07B(E).
標題:	Pharmaceutical sciences. -
電子資源:	http://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=3684953
ISBN:	9781321604504

Chemical investigation of candidate probiotics in aquaculture and formulation of a probiotic agent for oyster larviculure.
Dao, Christine Anh.

Chemical investigation of candidate probiotics in aquaculture and formulation of a probiotic agent for oyster larviculure. - 191 p.

Source: Dissertation Abstracts International, Volume: 76-07(E), Section: B.

Thesis (Ph.D.)--University of Rhode Island, 2015.

This item is not available from ProQuest Dissertations & Theses.

Probiotic agents are promising tools to reduce the risks of disease outbreaks in aquaculture facilities. Two marine bacteria, Bacillus pumilus RI0695 and Phaeobacter gallaeciensis S4, were previously reported to provide significant protection of the Eastern oyster larvae Crassostreae virginica when challenged with the shellfish pathogen Vibrio tubiashii. The goals of my dissertation research were to isolate and identify the antibiotic(s) secreted by Phaeobacter gallaeciensis S4, to chemically examine their mechanisms of action for probiotic activity, and to create probiotic formulations of Bacillus pumilus RI0695 and of Phaeobacter gallaeciensis S4 for delivery in shellfish larviculture facilities.

ISBN: 9781321604504Subjects--Topical Terms:

3173021
Pharmaceutical sciences.

Chemical investigation of candidate probiotics in aquaculture and formulation of a probiotic agent for oyster larviculure.
LDR:04987nmm a2200313 4500 001 2064254
005 20151109142630.5
008 170521s2015 ||||||||||||||||| ||eng d
020 $a 9781321604504
035 $a (MiAaPQ)AAI3684953
035 $a AAI3684953
040 $a MiAaPQ $c MiAaPQ
100 1 $a Dao, Christine Anh. $3 3178820
245 1 0 $a Chemical investigation of candidate probiotics in aquaculture and formulation of a probiotic agent for oyster larviculure.
300 $a 191 p.
500 $a Source: Dissertation Abstracts International, Volume: 76-07(E), Section: B.
500 $a Adviser: David Rowley.
502 $a Thesis (Ph.D.)--University of Rhode Island, 2015.
506 $a This item is not available from ProQuest Dissertations & Theses.
520 $a Probiotic agents are promising tools to reduce the risks of disease outbreaks in aquaculture facilities. Two marine bacteria, Bacillus pumilus RI0695 and Phaeobacter gallaeciensis S4, were previously reported to provide significant protection of the Eastern oyster larvae Crassostreae virginica when challenged with the shellfish pathogen Vibrio tubiashii. The goals of my dissertation research were to isolate and identify the antibiotic(s) secreted by Phaeobacter gallaeciensis S4, to chemically examine their mechanisms of action for probiotic activity, and to create probiotic formulations of Bacillus pumilus RI0695 and of Phaeobacter gallaeciensis S4 for delivery in shellfish larviculture facilities.
520 $a Chapter 2 describes the isolation and identification of the antibiotic tropodithietic acid (TDA) from Phaeobacter gallaeciensis S4. HPLC analysis of culture extracts from the tdaA-, tdaB- and tdbD- mutants confirmed loss of TDA production as compared to S4 wild type. Additional genetic mutant strains, clpX, rpoE-, exoP-, and complement strains rpoE- and exoP- were created by insertional mutagenesis to further explore the role of TDA and mechanisms regulating its production. UHPLC analysis of clpX stationary phase culture extracts confirmed the lost production of TDA when compared to a TDA standard. UHPLC analysis of complement strains clpX demonstrated that TDA was present compared to a TDA standard. The exoP- mutant produced TDA similar to the wild-type strain. Mutant strains that lack the production of TDA had less protection of Eastern oyster larvae C. virginica to bacterial challenge than the wild type or the genetic mutant strain that produced similar TDA concentrations as the wild type. This research determined that TDA was necessary for optimal probiotic activity.
520 $a Chapter 3 describes efforts to create a stable formulation of B. pumilus RI0695 for delivery at shellfish hatcheries. Currently there are no commercially available probiotics for shellfish aquaculture. Granulation is robust, cost effective, and simple proven method of formulation. A granular probiotic formulation of B. pumilus RI0695 was created by extruding dried B. pumilus RI0695 cells through three particle size sieves (40s, 80s, and 325s). Three granule sizes of 420 micro, 177 micro and 43 micro were successfully created. Granular (177 micro and 43 micro) formulations stored for 29 weeks and 22 weeks at room temperature (RT) were able to reduce mortality in C. virginica larvae and seed, respectively, when challenged with V. tubiashii. This study suggests the 43 micro granule formulation of B. pumilus RI0695 is a good candidate for commercial use in shellfish hatcheries.
520 $a In Chapter 4, a study is presented showing an effort to create a lyophilized probiotic formulation of P. gallaeciensis S4 that provides reduced mortality of C. virginica larvae when exposed to the shellfish pathogen V. tubiashii RE22. Several lyophilized formulations were prepared using varying amounts of two cryoprotectants at two growth stage phases of the bacterium. The two best formulations used log phase cells lyophilized with either 30% or and 40% mannitol as a cryoprotectant. The cell viabilities of the two formulations were measured under various storage conditions (27 °C, 4 °C, 30 °C, and 30 °C with 75% humidity) over a 5-week period. S4 formulations (30-M and 40-M) were tested at 1 week for probiotic protection of C. virginica seed against V. tubiashii infection. Unfortunately, the lyophilization process and storage significantly decreased the cell viability of both formulations (30-M and 40-M). Further, there was no protection of the larvae when pre-exposed to either formulation. Based on the in vivo results, a liquid P. gallaeciensis S4 formulation under starvation conditions in NSS medium was prepared. The liquid formulation maintained a cell viability of 108 CFU/mL over 8 weeks. (Abstract shortened by UMI.).
590 $a School code: 0186.
650 4 $a Pharmaceutical sciences. $3 3173021
690 $a 0572
710 2 $a University of Rhode Island. $b Pharmaceutical Sciences. $3 3173020
773 0 $t Dissertation Abstracts International $g 76-07B(E).
790 $a 0186
791 $a Ph.D.
792 $a 2015
793 $a English
856 4 0 $u http://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=3684953